Basic Information
| LncRNA/CircRNA Name | IGF2AS |
| Synonyms | NA |
| Region | GRCh38_11:2140501-2148666 |
| Ensemble | ENSG00000099869 |
| Refseq | NM_016412 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | neuroblastoma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot |
| Sample | tissues,NB cell lines |
| Expression Pattern | differential expression |
| Function Description | Further, we ranked and characterized the 35 lncRNAs according to their contribution towards the estimation accuracy. Functional annotations and co-expression gene analysis of LOC440896, LINC00632, and IGF2-AS revealed the association of co-expressed genes in Kyoto Encyclopedia of Genes and Genomes pathways. |
| Pubmed ID | 30914706 |
| Year | 2019 |
| Title | Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma. |
External Links
| Links for IGF2AS | GenBank HGNC NONCODE |
| Links for neuroblastoma | OMIM COSMIC |